Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

155 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Rivaroxaban for the prevention of outcomes in patients with atrial fibrillation in clinical practice: an indirect comparison of national and international registries.
Marin F, Fernández MS, Lekuona I, Arribas F, Barón-Esquivias G, Barrios V, Cosin-Sales J, Freixa-Pamias R, Masjuan J, Pérez-Cabeza AI, Schilling VR, Vázquez Rodríguez JM, Priu CR, Sánchez MA. Marin F, et al. Among authors: arribas f. J Comp Eff Res. 2022 Nov;11(16):1173-1184. doi: 10.2217/cer-2022-0111. Epub 2022 Sep 23. J Comp Eff Res. 2022. PMID: 36148923 Free article.
Comments on the 2016 ESC Guidelines for the Management of Atrial Fibrillation.
Arribas F; SEC Working Group for the 2016 ESC Guidelines for the Management of Atrial Fibrillation:; Arribas F, Roldán I, Luis Merino J, Roldán V, Arenal Ÿ, Tamargo J, Ruiz-Granell R, Mont L, Anguita M, Marín F; Reviewers for the 2016 ESC Guidelines for the Management of Atrial Fibrillation:; Barrios Alonso V, Barón G, Esquivias, Cosín Sales J, Díaz Infante E, Escobar Cervantes C, Ferreiro Gutiérrez JL, Guerra Ramos JM, Jiménez Candil FJ, Pérez Castellano N, Sambola Ayala A, Tello Montoliu A; SEC Guidelines Committee:; San Román A, Alfonso F, Arribas F, Evangelista A, Ferreira I, Jiménez M, Marín F, de Isla LP, Rodríguez Padial L, Sánchez PL, Sionis A, Vázquez R. Arribas F, et al. Rev Esp Cardiol (Engl Ed). 2017 Jan;70(1):2-8. doi: 10.1016/j.rec.2016.11.032. Rev Esp Cardiol (Engl Ed). 2017. PMID: 28038728 English, Spanish. No abstract available.
Ivabradine for chronic heart rate control in persistent atrial fibrillation. Design of the BRAKE-AF project.
Fontenla A, López-Gil M, Tamargo-Menéndez J, Matía-Francés R, Salgado-Aranda R, Rey-Blas JR, Miracle-Blanco Á, Mejía-Martínez E, Pastor-Fuentes A, Toquero-Ramos J, Arias MÁ, Montilla I, Gómez de la Cámara A, Arribas F; BRAKE-AF investigators. Fontenla A, et al. Among authors: arribas f. Rev Esp Cardiol (Engl Ed). 2020 May;73(5):368-375. doi: 10.1016/j.rec.2019.09.004. Epub 2019 Oct 17. Rev Esp Cardiol (Engl Ed). 2020. PMID: 31631048 Clinical Trial. English, Spanish.
Comments on the 2020 ESC/EACTS guidelines for the management of atrial fibrillation.
SEC Working Group for the 2020 ESC Guidelines for the Management of Atrial Fibrillation; Expert Reviewers for the 2020 ESC Guidelines for the Management of Atrial Fibrillation; SEC Guidelines Committee; Working Group for the 2020 ESC guidelines for the management of atrial fibrillation; Expert reviewers for the 2020 ESC guidelines for the management of atrial fibrillation; SEC Guidelines Committee. SEC Working Group for the 2020 ESC Guidelines for the Management of Atrial Fibrillation, et al. Rev Esp Cardiol (Engl Ed). 2021 May;74(5):378-383. doi: 10.1016/j.rec.2020.11.023. Epub 2021 Mar 15. Rev Esp Cardiol (Engl Ed). 2021. PMID: 33736964 English, Spanish. No abstract available.
Outcomes and predictive value of the 2MACE score in patients with atrial fibrillation treated with rivaroxaban in a prospective, multicenter observational study: The EMIR study.
Sanmartín Fernández M, Anguita Sánchez M, Arribas F, Barón-Esquivias G, Barrios V, Cosin-Sales J, Esteve-Pastor MA, Freixa-Pamias R, Lekuona I, Pérez-Cabeza AI, Ureña I, Vázquez Rodríguez JM, Rafols Priu C, Marin F. Sanmartín Fernández M, et al. Among authors: arribas f. Cardiol J. 2022;29(4):601-609. doi: 10.5603/CJ.a2022.0044. Epub 2022 May 27. Cardiol J. 2022. PMID: 35621092 Free PMC article.
Non-embolic outcomes in patients with cardiovascular disease and atrial fibrillation treated with rivaroxaban.
Marín F, Fernández MS, Barón-Esquivias G, Barrios V, Lekuona I, Pérez-Cabeza AI, Masjuan J, Del Vigo ER, Vázquez Rodríguez JM, Freixa-Pamias R, Schilling VR, Arribas F, Priu CR, Sánchez MA. Marín F, et al. Among authors: arribas f. J Comp Eff Res. 2023 Mar;12(3):e220049. doi: 10.57264/cer-2022-0049. Epub 2023 Feb 7. J Comp Eff Res. 2023. PMID: 36749006 Free PMC article.
Comparison of radiofrequency catheter ablation of drivers and circumferential pulmonary vein isolation in atrial fibrillation: a noninferiority randomized multicenter RADAR-AF trial.
Atienza F, Almendral J, Ormaetxe JM, Moya A, Martínez-Alday JD, Hernández-Madrid A, Castellanos E, Arribas F, Arias MÁ, Tercedor L, Peinado R, Arcocha MF, Ortiz M, Martínez-Alzamora N, Arenal A, Fernández-Avilés F, Jalife J; RADAR-AF Investigators. Atienza F, et al. Among authors: arribas f. J Am Coll Cardiol. 2014 Dec 16;64(23):2455-67. doi: 10.1016/j.jacc.2014.09.053. J Am Coll Cardiol. 2014. PMID: 25500229 Free article. Clinical Trial.
Treatment of atrial fibrillation in patients with enhanced sympathetic tone by pulmonary vein isolation or pulmonary vein isolation and renal artery denervation: clinical background and study design : The ASAF trial: ablation of sympathetic atrial fibrillation.
de Jong MR, Hoogerwaard AF, Adiyaman A, Smit JJJ, Ramdat Misier AR, Heeg JE, van Hasselt BAAM, Van Gelder IC, Crijns HJGM, Lozano IF, Toquero Ramos JE, Javier Alzueta F, Ibañez B, Rubio JM, Arribas F, Porres Aracama JM, Brugada J, Mont L, Elvan A. de Jong MR, et al. Among authors: arribas f. Clin Res Cardiol. 2018 Jul;107(7):539-547. doi: 10.1007/s00392-018-1214-6. Epub 2018 Feb 27. Clin Res Cardiol. 2018. PMID: 29487995 Clinical Trial.
155 results